Diseases, Conditions, Syndromes

Study suggests worsening trends in back pain management

Patient care could be enhanced and the health care system could see significant cost savings if health care professionals followed published clinical guidelines to manage and treat back pain, according to researchers at Beth ...

Diseases, Conditions, Syndromes

Full, limited range of motion extension exercise benefit LBP

(HealthDay)—A 12-week training program with isolated lumbar extension resistance training with either full range of motion (FullROM) or limited ROM (LimROM) increases full ROM lumbar extension strength and improves perceived ...

Diseases, Conditions, Syndromes

Correlates of care seeking ID'd for those with low back pain

(HealthDay)—Not all patients with low back pain (LBP) seek medical care, with female sex, LBP frequency, limitations in activities of daily living, and fear-avoidance beliefs contributing to increased odds of seeking care, ...

Diseases, Conditions, Syndromes

Glucosamine negatively affects lumbar discs

(HealthDay)—Glucosamine supplementation, which is often used for low back pain, has a detrimental effect on lumbar disc matrix homeostasis in an animal model of disc degeneration, according to a study published in the May ...

Diseases, Conditions, Syndromes

Duloxetine moderately cost-effective for treating back pain

(HealthDay)—Duloxetine is a moderately cost-effective treatment for chronic low back pain (CLBP) compared with other post-first-line oral medications, according to research published in the May 15 issue of Spine.

Medications

Xgeva approved for rare, non-malignant tumor

(HealthDay)—Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.

page 38 from 40